Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by Dude51on Jul 07, 2021 1:59pm

118 Views

Post# 33506131

Soon as we hit .03, squash it back down

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
13:53:43	V	0.025		18,000	7 TD Sec	2 RBC	K
13:50:52	V	0.025		20,000	85 Scotia	2 RBC	K
13:32:35	V	0.025		40,000	7 TD Sec	2 RBC	K
13:32:35	V	0.025		5,000	7 TD Sec	2 RBC	K
13:32:35	V	0.025		5,000	85 Scotia	2 RBC	K
13:20:04	V	0.03	0.005	670	7 TD Sec	68 Leede
13:20:04	V	0.03	0.005	2,000	7 TD Sec	7 TD Sec	K
13:16:39	A	0.025		36	7 TD Sec	85 Scotia	E
12:41:18	V	0.025		12,000	85 Scotia	9 BMO Nesbitt	K
12:41:18	D	0.025		400	85 Scotia	7 TD Sec	E